CD200 and breast cancer: Whereas CD200 knockdown by shRNA significantly reduced lung metastasis [42] and CD200-/- mice exhibited increased resistance to chemically induced papillomas [17], reduced metastasis burden in the 4THM breast cancer model in mice overexpressing CD200 has also been reported [18].